ClinVar Miner

Submissions for variant NM_015102.5(NPHP4):c.3364A>C (p.Thr1122Pro) (rs375836844)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000595557 SCV000707775 uncertain significance not provided 2017-10-25 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000778988 SCV000915426 uncertain significance NPHP4-Related Disorders 2018-11-19 criteria provided, single submitter clinical testing The NPHP4 c.3364A>C (p.Thr1122Pro) variant is a missense variant that has been reported in a compound heterozygous state with a frameshift variant in one individual with nephronophthisis (Otto et al. 2011). This variant was absent from 96 healthy control individuals but is reported at a frequency of 0.000213 in the European (non-Finnish) population of the Genome Aggregation Database. The evidence for this variant is limited. Based on the limited evidence, the p.Thr1122Pro variant is classified as a variant of uncertain significance but suspicious for pathogenicity for NPHP4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.